Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Risk factors for community transmission of SARS-CoV-2. A cross-sectional study in 116,678 people

Eyrun F. Kjetland, Karl Trygve Kalleberg, Camilla Lund Søraas, Bato Hammarström, Tor Åge Myklebust, Synne Jenum, Eyvind Axelsen, Andreas Lind, Roar Bævre-Jensen, Silje Bakken Jørgensen, Frank Olav Pettersen, Lene B. Solberg, Cathrine Lund Hadley, Mette S. Istre, Knut Liestøl, John Arne Dahl, Giske Ursin, View ORCID ProfileArne Søraas
doi: https://doi.org/10.1101/2020.12.23.20248514
Eyrun F. Kjetland
1Department of Microbiology, Oslo University Hospital, Oslo, Norway
2Discipline of Public Health Medicine, Nelson R Mandela School of Medicine, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: e.f.kjetland@medisin.uio.no arvsoe@ous-hf.no
Karl Trygve Kalleberg
3Age Labs AS, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Camilla Lund Søraas
8Department of Environmental and Occupational Medicine, Oslo University Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bato Hammarström
8Department of Environmental and Occupational Medicine, Oslo University Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tor Åge Myklebust
4Cancer Registry of Norway, Oslo, Norway
7Department of Research and Innovation, Møre and Romsdal Hospital Trust, Ålesund, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Synne Jenum
1Department of Microbiology, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eyvind Axelsen
9Fürst Medical Laboratory, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Lind
10The Department of Microbiology, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roar Bævre-Jensen
12Department of Medical Microbiology, Vestre Viken Hospital Trust, Drammen, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silje Bakken Jørgensen
14Department of Clinical Microbiology and Infection Control, Akershus University Hospital, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Olav Pettersen
1Department of Microbiology, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lene B. Solberg
12Department of Medical Microbiology, Vestre Viken Hospital Trust, Drammen, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cathrine Lund Hadley
3Age Labs AS, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mette S. Istre
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Knut Liestøl
13Department of Informatics, University of Oslo, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Arne Dahl
11Division of Orthopaedic Surgery, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giske Ursin
4Cancer Registry of Norway, Oslo, Norway
5Dept of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway
6Dept. of Preventive Medicine, University of Southern California (USC), Los Angeles, Calif, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arne Søraas
3Age Labs AS, Oslo, Norway
11Division of Orthopaedic Surgery, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Arne Søraas
  • For correspondence: e.f.kjetland@medisin.uio.no arvsoe@ous-hf.no
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The risk factors for SARS-CoV-2 transmission are not well characterised in Western populations. We sought to identify potential risk factors for transmission and actionable information to prevent for SARS-CoV-2.

Methods Individuals tested for SARS-CoV-2 at four major laboratories were invited. In addition, participants were sampled by convenience after a media campaign. Self-reported test results were compared with laboratory results, demographic data and behavioural facts were collected using a digital platform. In a cross-sectional design positive cases were compared with negative and untested control groups.

Findings Approximately 14 days after a countrywide lockdown in Norway, 116,678 participants were included. Median age was 46 years, 44% had children in preschool or in school; 18% were practicing health professionals. International flights, contact with infected, and gatherings of more than 50 people, were associated with high risk. Health professionals who used public transport were at higher risk of testing positive than those who did not. Having undergone light infections, the last six months was strongly associated with lower odds ratio of SARS-CoV-2 positivity. Contact with children, use of hand sanitiser and use of protective gloves in private were also associated with lower odds ratio of testing positive for SARS-CoV-2.

Interpretation Further research is needed to explore if being a parent or looking after children is associated with lower risk of SARS-CoV-2 positivity in the next phases of the pandemic. Immunological research should be done to determine the effects of prior trivial infections on SARS-CoV-2 infection. We confirm that large gatherings during the pandemic should be avoided and those who are infected, or under suspicion thereof, posed very high risks to others this population.

Competing Interest Statement

Dr Kalleberg and Dr Soraas received funding from the Research Council of Norway during the study. Dr Kalleberg, Dr Arne Soraas, and Dr Cathrine Lund Hadley report other support from Age Labs AS, outside the submitted work.

Clinical Trial

NTC 04320732

Funding Statement

Research Council of Norway supported the salaries of two of the authors during the work with the study. No other external funding was received.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Norwegian ethics committee (REK 124170) and followed the Helsinki Declaration.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data sharing is restricted by the informed consent form, the ethical approval committee and the European General Data Protection Regulation (GDPR). Upon request, in agreement with the above, the PI may be able grant partial access to an anonymized data set.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 24, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Risk factors for community transmission of SARS-CoV-2. A cross-sectional study in 116,678 people
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Risk factors for community transmission of SARS-CoV-2. A cross-sectional study in 116,678 people
Eyrun F. Kjetland, Karl Trygve Kalleberg, Camilla Lund Søraas, Bato Hammarström, Tor Åge Myklebust, Synne Jenum, Eyvind Axelsen, Andreas Lind, Roar Bævre-Jensen, Silje Bakken Jørgensen, Frank Olav Pettersen, Lene B. Solberg, Cathrine Lund Hadley, Mette S. Istre, Knut Liestøl, John Arne Dahl, Giske Ursin, Arne Søraas
medRxiv 2020.12.23.20248514; doi: https://doi.org/10.1101/2020.12.23.20248514
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Risk factors for community transmission of SARS-CoV-2. A cross-sectional study in 116,678 people
Eyrun F. Kjetland, Karl Trygve Kalleberg, Camilla Lund Søraas, Bato Hammarström, Tor Åge Myklebust, Synne Jenum, Eyvind Axelsen, Andreas Lind, Roar Bævre-Jensen, Silje Bakken Jørgensen, Frank Olav Pettersen, Lene B. Solberg, Cathrine Lund Hadley, Mette S. Istre, Knut Liestøl, John Arne Dahl, Giske Ursin, Arne Søraas
medRxiv 2020.12.23.20248514; doi: https://doi.org/10.1101/2020.12.23.20248514

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (180)
  • Allergy and Immunology (434)
  • Anesthesia (99)
  • Cardiovascular Medicine (949)
  • Dentistry and Oral Medicine (178)
  • Dermatology (111)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (423)
  • Epidemiology (9004)
  • Forensic Medicine (4)
  • Gastroenterology (421)
  • Genetic and Genomic Medicine (1962)
  • Geriatric Medicine (191)
  • Health Economics (405)
  • Health Informatics (1330)
  • Health Policy (662)
  • Health Systems and Quality Improvement (520)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10826)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1837)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (356)
  • Occupational and Environmental Health (470)
  • Oncology (1003)
  • Ophthalmology (299)
  • Orthopedics (111)
  • Otolaryngology (183)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (582)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1910)
  • Public and Global Health (4133)
  • Radiology and Imaging (676)
  • Rehabilitation Medicine and Physical Therapy (370)
  • Respiratory Medicine (551)
  • Rheumatology (226)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (178)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (82)